Genetic alterations in mouse lung tumors: Implications for cancer chemoprevention

Journal of Cellular Biochemistry

Volumn 67, Issue SUPPL. 28/29, 1997, Pages 49-63

  Herzog, Christopher R ^a   Lubet, Ronald A ^b   You, Ming ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Aberrant gene expression; Cancer chemoprevention; Genetic alteration; Mouse lung; Surrogate endpoint biomarkers

Indexed keywords

ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; PROTEIN P16; RETINOBLASTOMA PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER PREVENTION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DISEASE MARKER; GENE EXPRESSION; GENE LOSS; GENE MAPPING; GENE MUTATION; GENETIC DISORDER; GENETIC SUSCEPTIBILITY; LUNG ADENOMA; LUNG CANCER; LUNG TUMOR; MOUSE; NONHUMAN; ONCOGENE K RAS; ONCOGENE MYC; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; ANIMAL; DISEASE MODEL; GENETIC PREDISPOSITION; GENETICS; HUMAN; ONCOGENE; REVIEW;

ANIMALS; CHEMOPREVENTION; DISEASE MODELS, ANIMAL; GENES, TUMOR SUPPRESSOR; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG NEOPLASMS; MICE; ONCOGENES;

EID: 0031401656     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(1997)28/29+<49::AID-JCB6>3.0.CO;2-W     Document Type: Article

References (99)

1. Beckett WS (1993): Epidemiology and etiology of lung cancer. Clin Chest Med 14:1-15.
2. Fielding JE (1985): Smoking: Health effects and control. N Engl J Med 313:491-498.
3. Doll R, Hill A (1952): A study of the aetiology of carcinoma of the lung. Br Med J ii:1271-1286.
4. Minna JD (1993): The molecular biology of lung cancer pathogenesis. Chest 103:449s-456s.
5. DeMarini DM (1983): Genotoxicity of tobacco smoke and tobacco smoke condensate. Mutat Res 114:59-89.
6. Doll R, Peto R (1981): "The Causes of Cancer." Oxford: Oxford University Press.
7. Shimkin MB, Stoner GD (1975): Lung tumors in mice: Application to carcinogenesis bioassay. Adv Cancer Res 21:1-58.
8. You M, Candrian U, Maronpot RR, Stoner GD, Anderson M (1989): Activation of the K-ras gene in spontaneously occurring and chemically-induced strain A mouse lung tumors. Proc Natl Acad Sci USA 86:3070-3074.
9. Gariboldi M, Manenti G, Canzian F, Falvella FS, Radice MT, Pierotti MA, Della Porta G, Binelli G, Dragani TA (1993): A major susceptibility locus to murine carcinogenesis maps on chromosome 6. Nat Genet 3:132-136.
10. Herzog CR, Wiseman RW, You M (1994): Deletion mapping of a putative tumor suppressor gene on chromosome 4 in mouse lung tumors. Cancer Res 54:4007-4010.
11. Hegi ME, Soderkvist P, Foley JF, Schoonhove R, Swenberg JA, Kari F, Maronpot R, Anderson MW, Wiseman RW (1993): Characterization of p53 mutations in methylene chloride-induced lung tumors from B6C3F1 mice. Carcinogenesis 14:803-810.
12. Re FC, Manenti G, Borrello MG, Colombo MP, Fisher TH, Pierotti MA, Della Porta G, Dragani TA (1993): Multiple molecular alterations in mouse lung tumors. Mol Carcinog 5:155-160.
13. Knudson AG (1996): Hereditary cancer: Two hits revisited. J Cancer Res Clin Oncol 122:135-40.
14. Ooi WL, Elston RC, Chen VW, Bailey-Wilson JE, Rothschild H (1986): Increased familial risk for lung cancer. J Natl Cancer Inst 76:217-222.
15. Schwartz AG, Yang P, Swanson GM (1996): Familial risk of lung cancer among nonsmokers and their relatives. Am J Epidemiol 144:544-562.
16. Sellers TA, Bailey-Wilson JE, Elston RC, Wilson AF, Elston GZ, Ooi WL, Rothschild H (1990): Evidence for Mendelian inheritance in the pathogenesis of lung cancer. J Natl Cancer Inst 82:1272-1279.
17. Sellers TA, Bailey-Wilson JE, Elston RC, Rothschild H (1991): Evidence for Mendelian factors in early onset lung cancer. In: "Origins of Human Cancer: A Comprehensive Review." Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, pp 775-780.
18. Sellers TA, Bailey-Wilson JE, Potter JD, Rich SS, Elston RC, Rothschild H, Wilson AF (1992): Effect of cohort differences in smoking prevalence on models of lung cancer susceptibility. Genet Epidemiol 9:261-271.
19. Chen B, Johanson L, Wiest JS, Anderson MW, You M (1994): The second intron of the K-ras gene contains regulatory elements associated with mouse lung tumor susceptibility. Proc Natl Acad Sci USA 91:1589-1593.
20. Dragani TA, Manenti G, Pierotti MA (1995): Genetics of murine lung tumors. Adv Cancer Res 67:83-112.
21. Festing MFW, Yang A, Malkinson AM (1994): At least four genes and sex are associated with susceptibility to urethane-induced adenomas in mice. Genet Res 64:99-106.
22. Devereux TR, Wiseman RW, Kaplan N, Garren S, Foley JF, White CM, Anna C, Watson MA, Patel A, Jarchow S, Maronpot RR, Anderson MW (1994): Assignment of a locus for mouse lung tumor susceptibility to proximal chromosome 19. Mamm Genome 5:749-755.
23. Lin L, Festing MFW, Devereux TR, Crist K, Christiansen S, Wang Y, Yang A, Svenson K, Paigen A, Malkinson A, You M (1998): Additional evidence that the K-ras protooncogene is a candidate for the major mouse pulmonary adenoma susceptibility (Pas1) gene. Exp Lung Res (in press).
24. Festing MFW, Lin L, Devereux TR, Gao F, Yang A, Anna CH, White CM, Malkinson AM, You M (1998): Genes associated with sexual dimorphism and susceptibility to the chemical induction of lung adenomas in mice. Genomics (in press).
25. Devereux TR, Anna CH, Patel AC, White CM, Festing MFW, You M (1997): Smad4 (homolog of human DPC4) and Smad2 (homolog of human JV18-1): Candidates for murine lung tumor resistance and suppressor genes. Carcinogenesis 18:1751-1755.
26. Manenti G, Gariboldi M, Elango R, Fiorino A, De Gregorio L, Falvella FS, Hunter K, Housman D, Pierotti MA, Dragani TA (1996): Genetic mapping of a pulmonary adenoma resistance (Par1) in mouse. Nat Genet 12:455-457.
27. Obata M, Nishimori H, Ogawa K, Lee G-H (1996): Identification of the Par2 (Pulmonary resistance locus) on mouse chromosome 18, a major genetic determinant for lung carcinogen resistance in BALB/cByJ mice. Oncogene 13:1599-1604.
28. Fijneman RJA, deVries SS, Jansen RC, Demant P (1996): Complex interactions of new quantitative trait loci, Sluc1, Sluc2, Sluc3, and Sluc4, that influence the susceptibility to lung cancer in the mouse. Nat Genet 14:465-467.
29. Abujiang P, Nishimura M, Kamoto T, Ichioka K, Sato M, Hiai H (1997): Genetic resistance to urethane-induced pulmonary adenomas in SMXA RI strains. Cancer Res 57:2904-2908.
30. Ponder BA (1990): Inherited predisposition to cancer. Trends Genet 6:213-218.
31. Malkinson AM (1989): The genetic basis of susceptibility to lung tumors in mice. Toxicology 54:241-271.
32. Heston WE, Dunn TB (1951): Tumor development in susceptible strain A and resistant strain L lung transplants. J Natl Cancer Inst 11:1057-1071.
33. Shapiro JR, Kirschbaum AJ (1951): Intrinsic tissue response to induction of pulmonary tumors. Cancer Res 11:644-648.
34. Malkinson AM, Nesbitt MN, Skamene E (1985): Susceptibility to urethane-induced pulmonary adenomas between A/J and C57BL/6J mice: Use of AxB and BxA recombinant inbred lines indicating a three-locus genetic model. J Natl Cancer Inst 75:971-974.
35. Manenti G, Falvella FS, Gariboldi M, Dragani TA, Pierotti MA (1995): Different susceptibility to lung tumorigenesis in mice with an identical K-ras 2 intron 2. Genomics 29:438-444.
36. Malkinson AM, You M (1994): The oncospace hypothesis: The intronic structure of cancer-related genes regulates susceptibility to cancer. Mol Carcinog 10:61-65.
37. Chen B, You L, Wang Y, Stoner GD, You M (1994): Allele-specific activation and expression of the K-ras gene in hybrid mouse lung tumors induced by chemical carcinogens. Carcinogenesis 9:2031-2035.
38. Fearon ER, Cho KR, Nigro JM, Kern SE, Simons JW, Ruppert JM, Hamilton SR, Preisinger AC, Thomas G, Kinzler KW, Vogelstein B (1990): Identification of a chromosome 18q gene that is altered in colorectal cancers. Science 247:49-56.
39. Scheck AC, Coons SW (1993): Expression of the tumor suppressor gene DCC in human gliomas. Cancer Res 53:5605-5609.
40. Ekstrand BC, Mansfield T, Bigner S, Fearon ER (1995): DCC gene expression is altered by multiple mechanisms in brain tumors. Oncogene 11:2393-2402.
41. Keino-Masu K, Masu M, Hinck L, Leonardo ED, Chan SS-Y, Culotti JG, Tessier-Lavigne M (1996): Deleted in Colorectal Cancer (DCC) encodes a neurin receptor. Cell 87:175-185.
42. Klingelhutz AJ, Hedrick L, Cho KR, McDougal JK (1995): The DCC gene suppresses the malignant phenotype of transformed human epithelial cells. Oncogene 10:1581-1586.
43. INK4a tumor suppressor gene. Mamm Genome 8:65-66.
44. Stone S, Jiang P, Dayananth P, Tavtigian ST, Katcher H, Parry D, Peters G, Kamb A (1995): Complex structure and regulation of the p16 (MTS1) locus. Cancer Res 55:2988-2994.
45. INK4a-mediated growth suppression. Mol Cell Biol 16:1047-1057.
46. INK4 protein is restricted to the subset of lung cancer lines that retains wildtype RB. Oncogene 9:3375-3378.
47. Matzinger SA, Crist KA, Stoner GD, Anderson MW, Pereira MA, Steele VE, Kelloff GJ, Lubet RA, You M (1995): K-ras mutations in lung tumors from A/J and A/J x TSG-p53 F1 mice treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and phenethyl isothiocyanate. Carcinogenesis 16:2487-2492.
48. Chen B, Wang Y, You M (1998): Characterization of two protein binding sites in the second intron of the mouse K-ras gene. Proc Am Assoc Cancer Res 36:3365/565.
49. 1 (C57BL/6J X BALB/cJ) mice. Carcinogenesis 16:1065-1069.
50. 1 (A/J X C3H/HeJ) mice. Carcinogenesis 17:1735-1740.
51. 1 mice is due to the existence of a novel enhancer in the second intron. Proc Am Assoc Cancer Res 37:729/105.
52. Henriksson M, Luscher B (1996): Proteins of the myc network: Essential regulators of cell growth and differentiation. Adv Cancer Res 68:109-182.
53. Peukert K, Staller P, Schneider A, Carmichael G, Hanel F, Eilers M (1997): An alternative pathway for gene regulation by myc. EMBO J 16:5672-5686.
54. INK4a and of hyperphosphorylated retinoblastoma family proteins. EMBO J 16:5322-5333.
55. 1 mice: Frequent losses of heterozygosity in regions homologous to human tumor-suppressor genes. Proc Acad Natl Sci USA 91:3759-3763.
56. Hegi MD, Devereux TR, Dietrich WF, Cochran CJ, Lander ES, Foley JF, Maronpot RR, Anderson MW, Wiseman RW (1994): Allelotype analysis of mouse lung carcinomas reveals frequent allelic losses on chromosome 4 and an association between allelic imbalances on chromosome 6 and K-ras activation. Cancer Res 54:6257-6264.
57. Herzog CR, Chen B, Wang Y, Schut HAJ, You M (1996): Loss of heterozygosity on chromosomes 1, 11, 12, and 14 in hybrid mouse lung carcinomas. Mol Carcinogen 16:83-90.
58. Herzog CR, Wang Y, You M (1995): Allelic loss of distal chromosome 4 in mouse lung tumors localize a putative tumor suppressor gene to a region homologous with human chromosome 1p36. Oncogene 11:1811-1815.
59. INK4a -β in mouse lung tumor cells. Oncogene 13:1885-1892.
60. Cairns P, Polascik TJ, Eby Y, Tokino K, Califano J, Merlo A, Mao L, Herath J, Jenkins R, Westra W, Rutter JL, Buckler A, Gabrielson E, Tockman M, Cho KR, Hedrick L, Bova GS, Isaacs W, Koch W, Schwab D, Sidransky D (1995): Frequency of homozygous deletion at p16/CDKN2 in primary human tumors. Nat Genet 11:210-212.
61. INK4a transcript. Cancer Res 55:2995-2997.
62. Quelle DE, Zindy F, Ashmun RA, Sherr CJ (1995): Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 83:993-1000.
63. Ligget WH Jr, Sewell DA, Rocco J, Ahrendt SA, Koch W, Sidransky D (1996): p16 and p16 beta are potent growth suppressors of head and neck squamous carcinomas in vitro. Cancer Res 56:4119-4123.
64. Sherr CJ (1996): Cancer cell cycles. Science 274:1672.
65. INK4a alterations in 4-(Methymitrosamino)-1-(3-pyridyl)-1-butanone-induced mouse lung tumorigenesis. Proc Am Assoc Cancer Res 38:3135/469.
66. Santos J, Perez de Castro I, Herranz M, Pellicer A, Fernandez-Piqueras J (1996): Allelic losses on chromosome 4 suggest the existence of a candidate tumor suppressor gene region of about 0.6 cM in gamma-radiation-induced mouse primary thymic lymphomas. Oncogene 12:669-676.
67. Radany EH, Hong K, Kesharvarzi S, Lander ES, Bishop JM (1997): Mouse mammary tumor virus/v-Ha-ras transgenic-induced mammary tumors exhibit strain-specific allelic loss on mouse chromosome 4. Proc Natl Acad Sci USA 94:8664-8669.
68. Testa JR, Liu Z, Feder M, Bell DW, Balsara B, Cheng JQ, Taguchi T (1997): Advances in the analysis of chromosome alterations in human lung carcinomas. Cancer Genet Cytogenet 95:20-32.
69. INK4a in mouse lung tumors. Carcinogenesis 19:115-120.69.
70. Kamb A (1995): Cell-cycle regulators and cancer. Trends Genet 11:136-140.
71. INK4a in mouse fibroblasts as a function of replicative senescence and not retinoblastoma gene status. Oncogene 15:495-503.
72. Liu Q, Wiseman RW, Anderson M, You M (1994): Germline mutations in the p53 gene increase mouse lung tumor susceptibility. Proc Am Assoc Cancer Res 35:1091/182.
73. Stoner GD, Adam-Rodwell G, Morse MA (1993): Lung tumors in strain A mice: Application for studies in cancer chemoprevention. J Cell Biochem 17F:95-103.
74. Morse MA, Eklind KI, Hecht SS, Jordan KG, Choi C, Desai DH, Amin SG, Chung FL (1991): Structure-activity relationships for inhibition of 4-(methylnitros-amino)-1-(3-pyridyl)-1-butanone lung tumorigenesis by arylalkyl isothiocyanates in A/J mice. Cancer Res 51:1846-1850.
75. Wattenberg, LW (1992): Chemoprevention of cancer by naturally occurring and synthetic compounds. In Wattenberg LW, Lipkin M, Boone CW, Kelloff GJ (eds): "Cancer Chemoprevention." Boca Raton, FL: CRC Press, pp 19-39.
76. Pepin P, Bouchard L, Nicole P, Castonguay A (1992): Effects of sulindac and oltipraz on the tumorigenicity of 4-(methylnitrosamino)1-(3-pyridyl)-1-butanone in A/J mouse lung. Carcinogenesis 13:341-348.
77. Wattenberg LW (1985): Chemoprevention of cancer. Cancer Res 45:1-8.
78. Sparnins VL, Barany G, Wattenberg LW (1988): Effects of organosulfur compounds from garlic and onions on benzo[a]pyrene-induced neoplasia and glutathione S-transferase activity in the mouse. Carcinogenesis 9:131-134.
79. Hong JY, Wang ZY, Smith TJ, Zhou S, Shi S, Pan J, Yang CS (1992): Inhibitory effects of diallyl sulfide on the metabolism and tumorigenicity of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in A/J mouse lung. Carcinogenesis 13:901-904.
80. Shi ST, Wang ZY, Smith TJ, Hong JY, Chen WF, Ho CT, Yang CS (1994): Effects of green tea and black tea on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone bioactivation, DNA methylation, and lung tumorigenesis in A/J mice. Cancer Res 54:4641-4647.
81. Wattenberg LW, Coccia JB, Galbraith AR (1994): Inhibition of carcinogen-induced pulmonary and mammary carcinogenesis by chalcone administered subsequent to carcinogen exposure. Cancer Lett 83:165-169.
82. Wattenberg LW, Estensen RD (1996): Chemopreventive effects of myo-inositol and dexamethasone on benzo[a]pyrene and 4-(methylnitrosoamino)-1-(3-pyridyl)-1-butanone-induced pulmonary carcinogenesis in female A/J mice. Cancer Res 56:5132-5135.
83. Hawk MA, Cesen KT, Siglin JC, Stoner GD, Ruch RJ (1996): Inhibition of lung tumor cell growth in vitro and mouse lung tumor formation by lovastatin. Cancer Lett 109:217-222.
84. 1mouse lung. Proc Am Assoc Cancer Res 38: 2472/369.
85. You M, Wang Y, Stoner GD, You L, Maronpot RR, Reynolds SH, Anderson MW (1992): Parental bias of K-ras oncogenes detected in lung tumors from mouse hybrids. Proc Natl Acad Sci USA 89:5804-5808.
86. Fijneman RJA, Ophoff RA, Hart AAM, Demant P (1994): Kras-2 alleles, mutations, and lung tumor susceptibility in the mouse: An evaluation. Oncogene 9:1417-1421.
87. Dragani TA, Falvella FS, Manenti G, Pierotti MA, Gambetta RA (1996): Downexpression of aldehyde dehydrogenase 1 in murine lung tumors. Mol Carcinog 16:123-125.
88. Lin L, Wang Y, You M (1997): Detection of altered expression of mRNAs in mouse lung adenocarcinomas by differential screening of cDNA libraries. Proc Am Assoc Cancer Res 38:155-156/1043.
89. Yun TK, Kim SH, Lee YS (1995): Trial of a new medium-term model using benzo(a)pyrene-induced lung tumor in newborn mice. Anticancer Res 15:839-846.
90. Wattenberg LW, Leong JL (1970): Inhibition of the carcinogenic action of benzo(a)pyrene by flavones. Cancer Res 30:1922-1925.
91. Anderson LM, Priest LJ (1980): Reduction in the transplacental carcinogenic effect of methychloanthrene in mice prior to treatment with naphthoflavone. Res Commun Chem Pathol Pharmacol 30:431-446.
92. Lee YS, Kim TH, Cho KJ, Jang JAJ (1992): Inhibitory effects of biochanin A on benzo(a)pyrene induced carcinogenesis in mice. In Vivo 6:283-286.
93. Wattenberg LW, Estensen RD (1997): Studies of chempreventive effects of budenoside on benzo[a]pyrene-induced neoplasia of the lung of female A/J/ mice. Carcinogenesis 18:2015-2017.
94. Wattenberg LW, Wiedmann TS, Estensen RD, Zimmerman CL, Steele VE, Kelloff GJ (1997): Chemo-prevention of pulmonary carcinogenesis by aerosolized budesonide in female A/J mice. Cancer Res 57: 5489-5492.
95. Wattenberg LW, Coccia JB (1991): Inhibition of 4-(methylnitrosoamino)-1-(3-pyridyl)-1-butanone carcinogenesis in mice by D-limonene and citrus fruit oils. Carcinogenesis 12:115-117.
96. Lesca P (1983): Protective effects of ellagic acid and other plant phenols on benzo(a)pyrene-induced neoplasia in mice. Carcinogenesis 4:1651-1653.
97. Morse MA, LaGreca SD, Amin SG, Chung F-L (1990): Effects of indole-3-carbinol on lung tumorigenesis and DNA methylation induced by 4-(methylnitrosoamino)-1-(3-pyridyl)-1-butanone (NNK) and on the metabolism and disposition of NNK in A/J mice. Cancer Res 50:2613-2617.
98. Wattenberg LW (1980): Inhibition of polycyclic aromatic hydrocarbon-induced neoplasia by sodium cyanate. Cancer Res 40:232-234.
99. Athar M, Khan WA, Mukhtar H (1989): Effect of dietary tannic acid on epidermal, lung, and forestomach polycyclic aromatic hydrocarbon metabolism and tumorigenicity in Sencar mice. Cancer Res 49:5784-5788.